Project Grant HT94252510556
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$500K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
This $489,065 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at the University of North Carolina at Chapel Hill to investigate "Potentiated Chip Variants as Therapeutics to Alleviate Tau Pathology and Neurodegeneration." The research aims to develop innovative therapeutic approaches to address neurodegenerative conditions relevant to military service members and the broader public....
This federal Project Grant award from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), provides $509,979.00 to the University of North Carolina at Chapel Hill (UNC-CH) to support research on "Potentiated Chip Variants as Therapeutics to Alleviate Tau Pathology and Neurodegeneration." The funding will enable UNC-CH to conduct advanced biomedical research focused on transforming healthcare for military service...
This federal Project Grant award in the amount of $749,343.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to New York University School of Medicine. The award is for a research project titled "P15-1 PEPTIDE TREATMENT FOR CARTILAGE INJURIES AND POST-TRAUMATIC OSTEOARTHRITIS" with a performance period from August 1, 2025 to July 31, 2027. The grant supports advanced biomedical research focused on transforming...
This $1,541,280 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports the "The Breast Cancer Cellular Atlas" research initiative at the University of North Carolina at Chapel Hill. The project aims to advance biomedical research and transform healthcare for military service members and the broader public through innovative investigations spanning basic, applied, and translational...
This $544,250 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of North Carolina at Chapel Hill to develop combination therapies to overcome chemoresistance in Ewing sarcoma. The research project, which has a performance period from August 15, 2024 to August 14, 2027, aims to advance innovative therapeutic approaches to improve outcomes for this rare and aggressive form of cancer. As a...
The University of North Carolina at Chapel Hill received a $1,555,000 Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award will fund a 3-year research project to measure the autonomic nervous system responses of warfighters following exertion and resting stressors. This research aims to advance understanding of how the autonomic nervous system is impacted by physical and psychological stressors...
Duke University was awarded a $1,444,257 project grant from the Department of the Army Medical Command through its Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through September 2025 to develop new approaches for preventing chronic pain and neuroinflammation resulting from traumatic brain injury. Specifically, the grant supports investigation of neuroprotectin D1 and GPR37 signaling to transform treatment for service members...
This $322,800 federal Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research conducted by Mayo Clinic to investigate the role of osteoprotegerin as a mediator of post-traumatic osteoarthritis through a novel etiopathophysiological mechanism. The research project aims to advance scientific understanding and develop new treatments for this condition, which is particularly relevant for...
This $311,000 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will support the University of North Carolina at Chapel Hill (UNC-CH) in enhancing clinical trial discovery, matching, and enrollment for pancreatic ductal adenocarcinoma (PDAC) using fine-tuned large language models. The award, which runs from November 1, 2024 to October 31, 2026, will enable UNC-CH to develop innovative...
This federal Project Grant award in the amount of $1,645,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Trustees of Columbia University in the City of New York for the project "BONE FRACTURE-INDUCED JOINT BLEEDING AND POSTTRAUMATIC OSTEOARTHRITIS". The award period runs from May 1, 2025 to April 30, 2028. The funding supports advanced biomedical research initiatives focused on transforming healthcare for...